T-cell activation via dendritic cell antigen presentation

T-cell activation via dendritic cell antigen presentation is a fundamental immunological process where dendritic cells (DCs) process and present antigens to T-cells to initiate an adaptive immune response (Janeway et al., 2001). This interaction occurs at the immunological synapse and requires two primary signals: the recognition of peptide-MHC complexes by the T-cell receptor (TCR) and co-stimulation through molecules like CD80/86 binding to CD28 (Sharpe & Freeman, 2002). In cancer, this pathway is often suppressed by inhibitory checkpoints such as PD-1 or CTLA-4, which prevent effective anti-tumor T-cell responses (Pardoll, 2012). Conversely, overactivity of this pathway can lead to autoimmune diseases where T-cells attack self-tissues. Therapeutic interventions include checkpoint inhibitors to enhance T-cell activity in oncology and co-stimulation blockers like Abatacept to suppress T-cell activation in rheumatoid arthritis (Bluestone et al., 2006). This entry is classified as incorrect as a single target because it describes a complex biological pathway involving multiple distinct molecular targets rather than a single receptor or enzyme.

Other names

Antigen presentationImmunological synapseDC-T cell interactionT-cell primingMHC-restricted antigen presentation

Modulation of the immunological synapse by targeting co-stimulatory (e.g., CD28/CTLA-4) or inhibitory (e.g., PD-1/PD-L1) signaling pathways to regulate T-cell activation and effector function.